NOVEL PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS
申请人:Ritzén Andreas
公开号:US20100016303A1
公开(公告)日:2010-01-21
This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.
[EN] HETEROCYCLIC INHIBITORS OF ENPP1<br/>[FR] INHIBITEURS HÉTÉROCYCLIQUES D'ENPP1
申请人:VOLASTRA THERAPEUTICS INC
公开号:WO2021257614A1
公开(公告)日:2021-12-23
The present disclosure relates generally to inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), compositions thereof, and methods of using said compounds and compositions thereof. More specifically, the present disclosure relates to triazolopyrimidine and imidazolopyrimidine inhibitors of ENPP1 and methods of their use for treating disease mediated by ENPP1.
1,2,4-TRIAZOLO[1,5-a] PYRIMIDINE DERIVATIVE AS COPPER CORROSION INHIBITOR
申请人:ECOLAB USA INC.
公开号:US20200362467A1
公开(公告)日:2020-11-19
The present disclosure relates to corrosion inhibitor compositions, formulations, and compounds. The compositions, formulations, and compounds may be used is various methods to inhibit corrosion of metallic surfaces in aqueous environments. The corrosion inhibitor compositions may include one of the following compounds or any combination of any of the compounds of formula (I):
The instant invention provides for substituted fused pyrimidine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.